Skip to main content
SpringerLink
Log in

Clinical significance of gadobutrol in magnetic resonance imaging for the detection of myocardial infarction: matched-pair cohort study to compare with gadopentetate dimeglumine at standard dose

  • Published:
Radiological Physics and Technology Aims and scope Submit manuscript

Abstract

We aimed to confirm whether gadobutrol is more useful for late gadolinium enhancement (LGE) imaging than gadopentetate dimeglumine (Gd-DTPA) at the standard dose. Patients who underwent LGE imaging to assess myocardial infarction were retrospectively enrolled: gadobutrol, 51 cases; Gd-DTPA, 49 cases. Contrast ratios of infarcted lesion to remote myocardium (CRremote) and to left ventricular blood (CRblood) were compared. Patient characteristics that might affect image contrast did not differ between groups. CRremote (median, (interquartile range)) at 10 and 15 min after administration was 0.79 (0.08) and 0.70 (0.09) for gadobutrol, and 0.74 (0.13) and 0.65 (0.16) for Gd-DTPA (P < 0.05 and < 0.05), respectively. CRblood was − 0.05 (0.17) and − 0.002 (0.15) for gadobutrol, and − 0.05 (0.18) and 0.01 (0.16) for Gd-DTPA (P = 0.29 and = 0.22), respectively. Gadobutrol provided significantly better delineation of infarcted from normal myocardium than Gd-DTPA. Meanwhile, there was no difference in image contrast between infarcted myocardium and left ventricular blood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012;379:453–60.

    Article  Google Scholar 

  2. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown TD, Ismail NA, Dweck MR, Di Pietro E, Roughton M, Wage R, Daryani Y, O'Hanlon R, Sheppard MN, Alpendurada F, Lyon AR, Cook SA, Cowie MR, Assomull RG, Pennell DJ, Prasad SK. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309:896–908.

    Article  CAS  Google Scholar 

  3. Yoon YE, Kitagawa K, Kato S, Nakajima H, Kurita T, Ito M, Sakuma H. Prognostic significance of unrecognized myocardial infarction detected with MR imaging in patients with impaired fasting glucose compared with those with diabetes. Radiology. 2012;262:807–15.

    Article  Google Scholar 

  4. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15:91.

    Article  Google Scholar 

  5. Nijveldt R, Hofman MB, Hirsch A, Beek AM, Umans VA, Algra PR, Piek JJ, van Rossum AC. Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: cardiac MR imaging study. Radiology. 2009;250:363–70.

    Article  Google Scholar 

  6. Bulluck H, Dharmakumar R, Arai AE, Berry C, Hausenloy DJ. Cardiovascular magnetic resonance in acute ST-segment-elevation myocardial infarction: recent advances, controversies, and future directions. Circulation. 2018;137:1949–64.

    Article  Google Scholar 

  7. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113:2733–43.

    Article  Google Scholar 

  8. Durmus T, Schilling R, Doeblin P, Huppertz A, Hamm B, Taupitz M, Wagner M. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine. Invest Radiol. 2012;47:183–8.

    Article  Google Scholar 

  9. Wagner M, Schilling R, Doeblin P, Huppertz A, Luhur R, Schwenke C, Maurer M, Hamm B, Taupitz M, Durmus T. Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine. Eur Radiol. 2013;23:108–14.

    Article  Google Scholar 

  10. Doeblin P, Schilling R, Wagner M, Luhur R, Huppertz A, Hamm B, Taupitz M, Durmus T. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging. Eur J Radiol. 2014;83:660–4.

    Article  Google Scholar 

  11. Radiologysolutions.bayer.com. https://www.radiologysolutions.bayer.com/products/contrast-agents/gadavist-injection. Accessed 24 Apr 2020.

  12. Wildgruber M, Stadlbauer T, Rasper M, Hapfelmeier A, Zelger O, Eckstein HH, Halle M, Rummeny EJ, Huber AM. Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T. Invest Radiol. 2014;49:728–34.

    Article  CAS  Google Scholar 

  13. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

    Article  CAS  Google Scholar 

  14. De Cobelli F, Esposito A, Perseghin G, Sallemi C, Belloni E, Ravelli S, Lanzani C, Del Maschio A. Intraindividual comparison of gadobutrol and gadopentetate dimeglumine for detection of myocardial late enhancement in cardiac MRI. AJR Am J Roentgenol. 2012;198:809–16.

    Article  Google Scholar 

  15. Kellman P, Xue H, Olivieri LJ, Cross RR, Grant EK, Fontana M, Ugander M, Moon JC, Hansen MS. Dark blood late enhancement imaging. J Cardiovasc Magn Reson. 2016;18:77.

    Article  Google Scholar 

  16. Sharma P, Socolow J, Patel S, Pettigrew RI, Oshinski JN. Effect of Gd-DTPA-BMA on blood and myocardial T1 at 1.5T and 3T in humans. J Magn Reson Imaging. 2006;23:323–30.

    Article  Google Scholar 

  17. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology. 2014;270:834–41.

    Article  Google Scholar 

  18. Kanda T, Osawa M, Oba H, Toyoda K, Kotoku J, Haruyama T, Takeshita K, Furui S. High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology. 2015;275:803–9.

    Article  Google Scholar 

  19. Shen Y, Goerner FL, Snyder C, Morelli JN, Hao D, Hu D, Li X, Runge VM. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T. Invest Radiol. 2015;50:330–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Chiba Cerebral and Cardiovascular Center, 575 Tsurumai, Ichihara, Chiba, 290-0512, Japan

    Kohei Kawasaki, Tsutomu Nagatari, Masanobu Matsumoto & Takahiro Kageyama

  2. Department of Radiology, Chiba Cancer Center, 666-2 Nitonacyo Cyuo, Chiba, 260-8717, Japan

    Takumi Okubo

Authors
  1. Kohei Kawasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takumi Okubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tsutomu Nagatari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masanobu Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takahiro Kageyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kohei Kawasaki.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board (IRB) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Research involving human and/or animal participants

This article does not contain any studies with animals.

Informed consent

The IRB approval was obtained without patients’ informed consent because this work was retrospective study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawasaki, K., Okubo, T., Nagatari, T. et al. Clinical significance of gadobutrol in magnetic resonance imaging for the detection of myocardial infarction: matched-pair cohort study to compare with gadopentetate dimeglumine at standard dose. Radiol Phys Technol 13, 306–311 (2020). https://doi.org/10.1007/s12194-020-00569-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12194-020-00569-0

Keywords

Search

Navigation